Patient-centric care that was once the most sought-after trend for the pharma industry, has now gone mainstream. In this blog, Murali Krishnam, Vice President – Life Sciences Analytics Solutions, Saama Technologies, shares his experiences from the recently concluded Advanced Pharma Analytics USA Summit and also spotlights the new trends that will be steering the industry into the next growth wave.

I was recently at the Advanced Pharma Analytics USA conference, formerly known as Big DiP, focusing exclusively on Advanced Analytics topics. The event was themed around leveraging real world data for improving patient-centric approaches and enhancing value through better business decision making. There was a good blend of insights and trends presented from organizations across biopharma, academia, regulatory and patient-centric non-profits.

Patient-centric care has evolved from a mere concept to delivering more efficient, patient-centered system of care in which individuals (and providers) have real-time access and visibility into information. Technology companies are disrupting the industry with innovative solutions and access to real-time patient consented data is enabling newer business models. Some of the transformative business models include moving from post diagnostic care to preventive care and risk sharing between payers and members.